Additional information
Light brown Powder
66757-69-5
ACI-012807
227.3-228.0°C
C6H6O7
190.11
Ambient
2-8°C
Antioxidant
Pharmaceutical Impurity Standards
(2R)-2-[(2R)-3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl]-2-hydroxyacetic acid
(2R)-2-[(2R)-3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl]-2-hydroxyacetic acid
L-threo-Hex-?2-?enaric acid 1,?4-Lactone





![N-ETHYL AZILSARTAN MEDOXOMIL (25 mg) ((5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)